QA: AbbVie Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2022_AbbVie_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001551152, AbbVie Inc.

  xvar xval
0 AssetsCurrent 27,928,000,000
1 IntangibleAssetsNetIncludingGoodwill 108,330,000,000
2 PropertyPlantAndEquipmentNet 5,110,000,000
3 remainder_Assets 5,161,000,000
4 LiabilitiesCurrent 35,194,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,446,000,000
8 SellingGeneralAndAdministrativeExpense 12,349,000,000
9 ResearchAndDevelopmentExpense 8,046,000,000
10 remainder_Expenses 1,872,000,000
11 remainder_Revenues 56,197,000,000
12 remainder_NetIncome -4,935,000,000
13 remainder_ComprehensiveNetIncome 211,000,000
  yvar yval
0 Assets 146,529,000,000
1 Liabilities 35,194,000,000
2 Expenses 39,713,000,000
3 Revenues 56,197,000,000
4 StockholdersEquity 111,335,000,000
5 NetIncome 11,549,000,000
6 ComprehensiveNetIncome 11,654,500,000
7 BaseVar 141,389,500,000
8 EconomicCapitalRatio 2.24

Edgar->Model Mapping

Feature Distribution

Change over Time